Hypothermia and Hemostasis After Cardiac Arrest
- Conditions
- HypothermiaHeart ArrestHemostasisCoagulants
- Interventions
- Other: Therapeutic hypothermia
- Registration Number
- NCT02258360
- Lead Sponsor
- University of Aarhus
- Brief Summary
This is a sub-study to the Time-differentiated Therapeutic Hypothermia (TTH48, ClinicalTrials.gov Identifier: NCT01689077). TTH48 compares 24 with 48 hours of therapeutic hypothermia at a target temperature of 32-34°C in survivors of out-of-hospital cardiac arrest.
The overall aim of this sub-study is to examine the hemostasis in patients resuscitated after cardiac arrest and treated with 24 and 48 hours of therapeutic hypothermia
Our specific aims are:
* To investigate the whole blood coagulation using the rotational thromboelastometry.
* To investigate the function of platelets
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 82
- Out of hospital cardiac arrest of presumed cardiac cause
- Return of spontaneous circulation (ROSC)
- Glasgow Coma Score < 8
- Age > 18 years and < 80 years
- > 60 minutes from the circulatory collapse to ROSC
- Time interval > 4 hours from cardiac arrest to initiation of therapeutic hypothermia
- Terminal illness
- Coagulation disorder
- Unwitnessed asystolia
- Cerebral performance category 3-4 before the cardiac arrest
- Severe persistent cardiogenic shock
- Pregnancy
- Persistent cardiogenic shock (systolic blood pressure < 80 despite inotropic treatment)
- New apoplexy or intracerebral hemorrhage
- Lack of consent from the relatives
- Lack of consent from the GP
- Lack of consent from the patient if he/she wakes up and is relevant
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 24 hours hypothermia Therapeutic hypothermia Therapeutic hypothermia for 24 hours after reaching target temperature 48 hours hypothermia Therapeutic hypothermia Therapeutic hypothermia for 48 hours after reaching target temperature
- Primary Outcome Measures
Name Time Method Clotting time in seconds, EXTEM After 46 hours Measured by thomboelastometry on the ROTEM®
Area under the curve, COL-test After 46 hours Platelet function will be measured using Multiplate®
- Secondary Outcome Measures
Name Time Method Clot formation time in seconds, -EXTEM, INTEM, FIBTEM and HEPTEM After 22 hours, 46 hours and 70 hours Measured by thomboelastometry on the ROTEM®.
Maximum clot firmness (mm), -EXTEM, INTEM, FIBTEM and HEPTEM After 22 hours, 46 hours and 70 hours Measured by thomboelastometry on the ROTEM®.
Area under the curve, COL-test After 22 hours and 70 hours Platelet function will be measured using Multiplate®.
Clotting time in seconds, EXTEM After 22 hours and 70 hours Measured by thomboelastometry on the ROTEM®.
Clotting time in seconds, -INTEM, FIBTEM and HEPTEM After 22 hours, 46 hours and 70 hours Measured by thomboelastometry on the ROTEM®.
Maximum velocity (mm/min), -EXTEM, INTEM, FIBTEM and HEPTEM After 22 hours, 46 hours and 70 hours Measured by thomboelastometry on the ROTEM®.
Area under the curve, Thrombin generation After 22 hours, 46 hours and 70 hours Area under the curve,- ADP, ASPI and TRAP-test. After 22 hours, 46 hours and 70 hours Platelet function will be measured using Multiplate®.
Time to maximum velocity (s), -EXTEM, INTEM, FIBTEM and HEPTEM After 22 hours, 46 hours and 70 hours Measured by thomboelastometry on the ROTEM®.
Area under the curve, Clot stability test After 22 hours, 46 hours and 70 hours
Trial Locations
- Locations (1)
Dept of Anesthesiology and Intensive Care and Dept of Clinical Biochemistry, Aarhus University Hospital, Skejby
🇩🇰Aarhus, Aarhus N, Denmark